Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$9.91B |
| 2 |
SPCX
SpaceX
SPCX
|
+$871M |
| 3 |
Eli Lilly
LLY
|
+$719M |
| 4 |
Amazon
AMZN
|
+$698M |
| 5 |
Netflix
NFLX
|
+$627M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Micron Technology
MU
|
+$3B |
| 2 |
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$1.54B |
| 3 |
TSMC
TSM
|
+$1.42B |
| 4 |
NVIDIA
NVDA
|
+$1.41B |
| 5 |
SNDK
Sandisk
SNDK
|
+$771M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 82.67% |
| 2 | Technology | 3.92% |
| 3 | Healthcare | 2.55% |
| 4 | Industrials | 2.24% |
| 5 | Financials | 2.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
13276
CALL
Gossamer Bio
GOSS
$63.4M
| $25.8K | ﹤0.01% |
1,958
-793
| -29% | -$17.7K |
|
13277
Clearmind Medicine
CMND
$1.28M
| $25.8K | ﹤0.01% |
+11,710
| New | +$66.6K |
|
|
NNDM
13278
Nano Dimension
NNDM
$323M
| $25.7K | ﹤0.01% |
17,751
-76,475
| -81% | -$125K |
|
13279
PUT
Neonode
NEON
$13.8M
| $25.6K | ﹤0.01% |
27,200
+5,700
| +27% | +$8.46K |
|
|
RENX
13280
RenX Enterprises
RENX
$4.58M
| $25.4K | ﹤0.01% |
+13,512
| New | +$28.2K |
|
13281
GlucoTrack
GCTK
$1.81M
| $25.4K | ﹤0.01% |
+5,302
| New | +$49.9K |
|
|
MVO
13282
DELISTED
MV Oil Trust
MVO
| $25.3K | ﹤0.01% |
14,286
-5,549
| -28% | -$11.6K |
|
|
CURX
13283
Curanex Pharmaceuticals
CURX
$6.73M
| $25.3K | ﹤0.01% |
4,763
+2,235
| +88% | +$16.3K |
|
|
CHGA
13284
Change Agents Corp
CHGA
$2.09M
| $25.3K | ﹤0.01% |
4,340
+1,531
| +55% | +$11.8K |
|
13285
Equus Total Return
EQS
$13.4M
| $25.2K | ﹤0.01% |
+20,330
| New | +$27.1K |
|
13286
Elevai Labs
ELAB
$3.9M
| $25K | ﹤0.01% |
+2,070
| New | +$52.4K |
|
13287
PUT
Wrap Technologies
WRAP
$98.8M
| $25K | ﹤0.01% |
+19,400
| New | +$27.4K |
|
13288
Ensysce Biosciences
ENSC
$8.79M
| $25K | ﹤0.01% |
86,193
+28,830
| +50% | +$10.4K |
|
13289
Nexalin Technology
NXL
$4.02M
| $24.9K | ﹤0.01% |
+2,513
| New | +$31K |
|
13290
IT Tech Packaging
ITP
$2.71M
| $24.9K | ﹤0.01% |
134,388
+115,305
| +604% | +$22.5K |
|
13291
Rekor Systems
REKR
$60.4M
| $24.9K | ﹤0.01% |
35,775
-2,415
| -6% | -$1.89K |
|
13292
PUT
Skye Bioscience
SKYE
$9.34M
| $24.5K | ﹤0.01% |
4,425
-3,050
| -41% | -$19.2K |
|
|
NXDR
13293
PUT
Nextdoor Holdings
NXDR
$952M
| $24.5K | ﹤0.01% |
10,800
-75,500
| -87% | -$141K |
|
|
ALPS
13294
ALPS Group Inc
ALPS
$66.6M
| $24.5K | ﹤0.01% |
+42,160
| New | +$34.6K |
|
|
GPMT
13295
CALL
Granite Point Mortgage Trust
GPMT
$43.1M
| $24.3K | ﹤0.01% |
+16,200
| New | +$23.3K |
|
13296
PUT
Microvision
MVIS
$46.8M
| $24.1K | ﹤0.01% |
4,907
+1,214
| +33% | +$10K |
|
|
YRD
13297
CALL
Yiren Digital
YRD
$88.4M
| $24K | ﹤0.01% |
28,700
-17,800
| -38% | -$29.4K |
|
13298
CALL
Coherus Oncology
CHRS
$205M
| $23.9K | ﹤0.01% |
17,100
-21,000
| -55% | -$34.3K |
|
13299
SOBR Safe
SOBR
$1.09M
| $23.9K | ﹤0.01% |
+32,508
| New | +$30.5K |
|
|
GRI
13300
GRI Bio
GRI
$3.98M
| $23.7K | ﹤0.01% |
+13,376
| New | +$29.6K |
|
Similar funds
Citadel Advisors's Q2 2026 Portfolio in Review
As of Q2 2026, Citadel Advisors held 15,445 positions worth $875B, up 41% from $618B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Citadel Advisors's Q2 2026 filing shows 2,573 new, 6,088 increased, 4,803 reduced and 1,873 closed positions. Its largest new stake was SpaceX: 5,129,884 shares worth $876M. The largest sale was Micron Technology, an estimated $3B.
By sector, the portfolio is most concentrated in Miscellaneous at 83% of assets, up from 79% a quarter earlier, followed by Technology and Healthcare.
- Citadel Advisors's largest Q2 2026 buy was SpaceX: 5,129,884 shares worth $876M.
- Citadel Advisors added most to iShares Core S&P 500 ETF in Q2 2026, an estimated $9.91B increase.
- Citadel Advisors's biggest Q2 2026 reduction was Micron Technology, cutting an estimated $3B.
- Citadel Advisors fully exited iShares 7-10 Year Treasury Bond ETF in Q2 2026, selling an estimated $325M.
- Citadel Advisors's ten largest holdings make up 23% of its $875B portfolio in Q2 2026.
- Citadel Advisors opened 2,573 new positions and closed 1,873 in Q2 2026.
- Citadel Advisors's portfolio value rose 41% quarter-over-quarter to $875B.
Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.